help button home button Am J Pathol Angiogenesis Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watson, M. A.
Right arrow Articles by Perry, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watson, M. A.
Right arrow Articles by Perry, A.
(American Journal of Pathology. 2002;161:665-672.)
© 2002 American Society for Investigative Pathology


Regular Articles

Molecular Characterization of Human Meningiomas by Gene Expression Profiling Using High-Density Oligonucleotide Microarrays

Mark A. Watson*, David H. Gutmann{dagger}, Kelly Peterson*, Michael R. Chicoine{ddagger}, Bette K. Kleinschmidt-DeMasters§, Henry G. Brown and Arie Perry*

From the Departments of Pathology and Immunology,*Neurology,{dagger}and Neurosurgery,{ddagger}Washington University School of Medicine, St. Louis, Missouri; the Department of Pathology,§University of Colorado Health Sciences Center, Denver, Colorado; and the Department of Pathology,Allegheny General Hospital, Pittsburgh, Pennsylvania

Meningiomas are common central nervous system neoplasms that exhibit remarkably diverse histopathology and biological behavior. Compared to astrocytomas, the most common central nervous system tumor, little is known about the molecular pathways critical for meningioma tumor formation and malignant progression. As an initial step toward characterizing the genetic basis of meningioma pathogenesis, we assessed cancer-related gene expression profiles of nonneoplastic leptomeningeal specimens and human meningiomas of varying World Health Organization (WHO) grade using high-density oligonucleotide microarrays. Although expression profile differences between nonneoplastic and meningioma specimens were readily discernible, the expression profile of a subset of genes could also distinguish WHO grade I from WHO grades II and III tumors. Altered expression levels of several genes identified in this study have been previously noted in meningiomas (eg, growth hormone receptor, IGFBP-7, endothelin receptor A, IGF2). However, we also identified a number of novel genes whose expression was associated with WHO grade and was confirmed by reverse transcriptase-polymerase chain reaction in a larger, independent set of meningeal tumors (n = 47). This report represents the first gene expression profiling studies of meningiomas and identifies some initial candidate genes that may provide further insights into the genetic basis for meningioma pathogenesis.





This article has been cited by other articles:


Home page
Cancer Res.Home page
E. B. Claus, P. J. Park, R. Carroll, J. Chan, and P. M. Black
Specific Genes Expressed in Association with Progesterone Receptors in Meningioma
Cancer Res., January 1, 2008; 68(1): 314 - 322.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
S. A. M. Thomson, E. Kennerly, N. Olby, J. R. Mickelson, D. E. Hoffmann, P. J. Dickinson, G. Gibson, and M. Breen
Microarray Analysis of Differentially Expressed Genes of Primary Tumors in the Canine Central Nervous System
Vet. Pathol., September 1, 2005; 42(5): 550 - 558.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. A. Lusis, M. A. Watson, M. R. Chicoine, M. Lyman, P. Roerig, G. Reifenberger, D. H. Gutmann, and A. Perry
Integrative Genomic Analysis Identifies NDRG2 as a Candidate Tumor Suppressor Gene Frequently Inactivated in Clinically Aggressive Meningioma
Cancer Res., August 15, 2005; 65(16): 7121 - 7126.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Mawrin, T. Sasse, E. Kirches, S. Kropf, T. Schneider, C. Grimm, C. Pambor, C. K. Vorwerk, R. Firsching, U. Lendeckel, et al.
Different Activation of Mitogen-Activated Protein Kinase and Akt Signaling Is Associated with Aggressive Phenotype of Human Meningiomas
Clin. Cancer Res., June 1, 2005; 11(11): 4074 - 4082.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
B. Suarez-Merino, M. Hubank, T. Revesz, W. Harkness, R. Hayward, D. Thompson, J. L. Darling, D. G.T. Thomas, and T. J. Warr
Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3
Neuro-oncol, January 1, 2005; 7(1): 20 - 31.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. R. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey, and A. M. Chinnaiyan
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression
PNAS, June 22, 2004; 101(25): 9309 - 9314.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. M. Fathallah-Shaykh, B. He, L.-J. Zhao, H. H. Engelhard, L. Cerullo, T. Lichtor, R. Byrne, L. Munoz, K. Von Roenn, G. L. Rosseau, et al.
Genomic Expression Discovery Predicts Pathways and Opposing Functions behind Phenotypes
J. Biol. Chem., June 20, 2003; 278(26): 23830 - 23833.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society for Investigative Pathology.